REFERENCES
1. Baumgartner H, Falk V, Bax JJ, et al. ESC/EACTS Guidelines for the man Agement of valvular heart disease. Eur Heart J . 2017; 38: 2739-2791.
2. Lung B, Baron G, Tornos P, et al. Valvular heart disease in the community: a Eu Ropean experience. Curr Probl Cardiol . 2007; 32: 609-661.
3. Galloway AC, Grossi EA et al. Operative therapy for mitral insufficiency from coronary artery disease. Semin. Thorac.Cardiovasc. Surg . 1995; 7:227-232.
4. Praet KMV, Stamm C, Sündermann SH, et al. Minimally invasive surgical mitral valve repair: state of the art review. Interv Cardiol . 2018; 13: 14-19.
5. Bonow RO, Carabello BA, Kanu C, de LA, Jr, Faxon DP, Freed MD, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angio graphy and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84-231. repair and revascularization for ischemic mitral regurgitation: predictors of operative mortality and survival. J Heart Valve Dis 2002; 11:793-800.
6. Akar AR, Doukas G, Szafranek A, Alexiou C, Boehm MC, Chin D, et al. Mitral valve 2005;28:361-362.
7. Akar AR, Ozyurda U. Surgery for ischemic mitral valve prolapse. Eur J Cardiothorac Surg 2005;28:361-362.
8. American Heart Association Heart Facts. Dallas American Heart Association National C.P1,1990.
9 . David TE. Techniques and results of mitral valve repair for ischemic mitral regurgitation. J Card Surg . 1994; 9 (23): 274-281.
10. Hendren WG, Nemec JJ, Lytle BW et al. Mitral valve repair for ischemic mitral insufficiency. Ann Thorac Surg . 1991;52:1246-51.
11. Bulkley BH, Roberts WC. Dilatation of the mitral annulus. A rare cause of mitral regurgitation. Am J Med. 1975;59:457.
12. Oury JH, Cleveland JC, Duran CG, Angell WW. Ischemic mitral valve disease; Classification and systemic approach to management.J Card Surg . 1995;9(Suppl):262-73.
13. David TE. Techniques and results of mitral valve repair for ischemic mitral regurgitation. J Card Surg. 1994; 9 (Suppl 23): 274-281.
14. Akins CW, Hilgenberg AD, Buckley MJ et al. Mitral valve reconstruction versus replacement for degenerative or ischemic mitral regurgitation. Ann Thorac Surg . 1994; 58: 668-676.
15 . Zanaboni G, Dyne KM, Rossi A, et al. Prolidase deficiency: biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients. Haematologica. 1994; 79:13-18.
16 . Palka JA, Phang JM. Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors. J Cell Biochem. 1997; 67:166-175.
17. McRae PA, Porter BE. The perineuronal net component of the extracellular matrix in plasticity and epilepsy. Neurochem Int.2012; 61: 963-972.
18. Hauptmann M, Wilson DF, Erecinska M. High affinity proline uptake in rat brain synaptosomes. FEBS Lett . 1983;161:301-305.
19. Crump FT, Fremeau RT, Craig AM. Localization of the brain-specific high-affinity Iproline transporter in cultured hippocampal neurons:molecular heterogeneity of synaptic terminals.Mol Cell Neurosci. 1999; 13:25- 39.
20. Horoz M, Aslan M, Bolukbas FF, et al. Serum prolidase enzyme activity and its relation to histopathological findings in patients with nonalcoholic steatohepatitis. J Clin Lab Anal.2010; 24:207-211.
21. Rabus M, Demirbag R, Sezen Y, et al. Plasma and tissue oxidative stress index in patients with rheumatic and degenerative heart valve disease. Turk Kardiyol Dern Ars. 2008; 36:536-540.
22. Yıldız B, Demirbağ R, Yılmaz R, Gür M, Altıparmak IH, Akyol S, Aksoy N, Ocak AR, Erel O. The association of serum prolidase activity with the presence and severity of coronary artery disease.Coron Artery Dis. 2008 Aug;19(5):319-25. doi: 10.1097/MCA.0b013e32830042ba.
23. Gillinov AM, Wierup PN, Blackstone EH, Bis-hay ES, Cosgrove DM, White J, Lytle BW, McCarthy PM. Is repair preferable to replacement for ischemic mitral regurgitation? J Thorac Cardiovasc Surg.2001;122:1125-41.
24. Demirbağ R, Yıldız A, Gur M, Yilmaz R, Elçi K, Aksoy N. Serum prolidase activity in patients with hypertension and itsrelation with left ventricular hypertrophy. Clinical Biochemistry . 2007; (40): 1020–1025.
25. Koçarslan A, Koçarslan S, Aydın M.S, Altıparmak İ.H, Demir D, Sezen H, Yüce H.H, Göz M. Archives of Medical Research. 2016; (47): 200-206.
26. Rabus M, Demirbag R, Sezen Y, et al. Plasma and tissue oxidative stress index in patients with rheumatic and degenerative heart valve disease. Turk Kardiyol Dern Ars. 2008;36:536 - 540.
27. Yildiz A, Demirbag R, Yilmaz R, et al. The association of serum prolidase activity with the presence and severity of coronary artery disease. Coron Artery Dis. 2008;19:319 - 325.